BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 10895712)

  • 1. St. John's Wort: is it effective and harmless?
    Biron CR
    RDH; 1999 Jun; 19(6):74-6. PubMed ID: 10895712
    [No Abstract]   [Full Text] [Related]  

  • 2. St. John's wort.
    Lawvere S; Mahoney MC
    Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperforin in extracts of St John's wort (Hypericum perforatum) for depression.
    Vormfelde SV; Poser W
    Arch Intern Med; 2000 Sep; 160(16):2548-9. PubMed ID: 10979074
    [No Abstract]   [Full Text] [Related]  

  • 5. St John's wort: Prozac from the plant kingdom.
    Di Carlo G; Borrelli F; Ernst E; Izzo AA
    Trends Pharmacol Sci; 2001 Jun; 22(6):292-7. PubMed ID: 11395157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. St John's Wort and literature quotations.
    Mennini T; Gobbi M; Morazzoni P
    Arch Intern Med; 2001 Apr; 161(7):1016-7. PubMed ID: 11295979
    [No Abstract]   [Full Text] [Related]  

  • 7. St. John's wort: role of active compounds for its mechanism of action and efficacy.
    Butterweck V; Schmidt M
    Wien Med Wochenschr; 2007; 157(13-14):356-61. PubMed ID: 17704987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining hyperforin and hypericin content in eight brands of St. John's wort.
    de los Reyes GC; Koda RT
    Am J Health Syst Pharm; 2002 Mar; 59(6):545-7. PubMed ID: 11908248
    [No Abstract]   [Full Text] [Related]  

  • 9. Variability in St. John's wort formulations is an important consideration.
    Kroll DJ; Shaw HS; Wall ME; Oberlies NH
    Altern Ther Health Med; 2001; 7(6):21-2. PubMed ID: 11712467
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
    Ng QX; Venkatanarayanan N; Ho CY
    J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of St John's wort in depression : what is known?
    Butterweck V
    CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypericum perforatum: nature's mood stabilizer.
    Kumar V; Singh PN; Muruganandam AV; Bhattacharya SK
    Indian J Exp Biol; 2000 Nov; 38(11):1077-85. PubMed ID: 11395949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
    Laakmann G; Schüle C; Baghai T; Kieser M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [St. John's wort--scientific tests. Report of an expert workshop in Berlin].
    Beise U
    Rev Med Suisse Romande; 2000 Jun; 120(6):543-6. PubMed ID: 11014100
    [No Abstract]   [Full Text] [Related]  

  • 15. St. John's what?
    Golden F
    Time; 2001 Apr; 157(17):60-1. PubMed ID: 11347492
    [No Abstract]   [Full Text] [Related]  

  • 16. St John's wort for depression: a systematic review.
    Gaster B; Holroyd J
    Arch Intern Med; 2000 Jan; 160(2):152-6. PubMed ID: 10647752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of Hypericum extract in mildly to moderately depressed outpatients: a review based on data from three randomized, placebo-controlled trials.
    Trautmann-Sponsel RD; Dienel A
    J Affect Disord; 2004 Oct; 82(2):303-7. PubMed ID: 15488262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Charge conformity and biopharmaceutic characterization. St. John's Wort extract preparations in comparison].
    Wurglics M; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2003; 32(3):236-41. PubMed ID: 12784544
    [No Abstract]   [Full Text] [Related]  

  • 19. St. John's Wort.
    Field HL; Monti DA; Greeson JM; Kunkel EJ
    Int J Psychiatry Med; 2000; 30(3):203-19. PubMed ID: 11209989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?
    Laggner H; Schreier S; Hermann M; Exner M; Mühl A; Gmeiner BM; Kapiotis S
    Free Radic Res; 2007 Feb; 41(2):234-41. PubMed ID: 17364950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.